Is Provenge for you?
Provenge, despite its demonstrated survival advantage, continues to be knocked as a viable treatment for men with castrate-resistant prostate cancer. What is Provenge? Provenge is immunotherapy for men with metastatic castrate-resistant prostate cancer. In [...]
Weekend And July Hospitalizations Worsen Outcomes for Metastatic Prostate Cancer Survivors
Oh, those weekends, don’t you just love them? They provide us with an opportunity to spend time with our families, drive to the country house or go to the theater. Now, we know they also [...]
Describing My Experience Being Diagnosed With A Fifth Cancer – A Video To Watch
I attend the American Society of Clinical Oncology (ASCO) meeting in Chicago in May. As usual, it was exciting and it provides me with a fantastic opportunity to catch up with the current research in [...]
On Hormone Therapy – To Statin Or Not, That Is The Question
JAMA Oncology has published a new study that suggests that adding a statin drug at the initiation of hormone therapy (ADT) to the treatment protocol for a man with progressive, hormone-sensitive prostate cancer may significantly [...]
Take the Prostate Cancer Experience
Click Here to Take the Prostate Cancer Experience The Prostate Cancer Experience study at will help us understand the truth of how prostate cancer treatment affects day to day living. There are many different kinds [...]
CDC Funding For Prostate Cancer Saved
The line item for FY 2016 CDC prostate cancer funding of $13,205,000 is restored in both the House and Senate appropriations bills, as authored by their committees. Thanks to the several thousand of you who [...]